| Literature DB >> 23864868 |
Laurence Pascal1, Mathilde Pascal, Morgane Stempfelet, Sarah Goria, Christophe Declercq.
Abstract
The Etang-de-Berre area is a large industrialized area in the South of France, exposing 300,000 inhabitants to the plumes of its industries. The possible associated health risks are of the highest concern to the population, who asked for studies investigating their health status. A geographical ecological study based on standardized hospitalizations ratios for cancer, cardiovascular, and respiratory diseases was carried out over the 2004-2007 period. Exposure to air pollution was assessed using dispersion models coupled with a geographic information system to estimate an annual mean concentration of sulfur dioxide (SO₂) for each district. Results showed an excess risk of hospitalization for myocardial infarction in women living in districts with medium or high SO₂ exposure, respectively, 38% [CI 95% 4 : 83] and 54% [14 : 110] greater than women living in districts at the reference level exposure. A 26% [2 : 57] excess risk of hospitalization for myocardial infarction was also observed in men living in districts with high SO₂ levels. No excess risk of hospitalization for respiratory diseases or for cancer was observed, except for acute leukemia in men only. Results illustrate the impact of industrial air pollution on the cardiovascular system and call for an improvement of the air quality in the area.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23864868 PMCID: PMC3706020 DOI: 10.1155/2013/328737
Source DB: PubMed Journal: J Environ Public Health ISSN: 1687-9805
Figure 1Study area and localization of air quality monitoring stations.
Figure 2The industrial surrounding of Etang-de-Berre area. High and low level refers to the European Council Directive 96/82/EC of 9 December 1996 on the control of major-accident hazards involving dangerous substances.
Annual mean, maximum daily mean, and maximum hourly mean of SO2 concentrations (µg·m−3) measured by monitoring stations located in the study area and in the remaining part of the regional area (2008 data).
| Monitoring station | Type | Annual mean | Maximum daily mean | Maximum hourly mean |
|---|---|---|---|---|
| Study area | ||||
|
| ||||
| Berre-l'Etang | Urban | 7 | 66 | 190 |
| Berre Magasin | Urban | 4 | 29 | 160 |
| Carry-le-Rouet | Industrial | 6 | 41 | 200 |
| Chateauneuf/La Mède | Industrial | 5 | 74 | 404 |
| Chateauneuf les Martigues | Industrial | 4 | 28 | 124 |
| Fos-sur-Mer | Urban | 15 | 138 | 427 |
| Fos-sur-Mer/les Carabins | Urban | 2 | 33 | 200 |
| Istres | Urban | 5 | 33 | 125 |
| La Fare les Oliviers | Industrial | 5 | 22 | 122 |
| Marignane ville | Urban | NA | 32 | 221 |
| Martigues l'île | Urban | 7 | 43 | 327 |
| Martigues La Couronne | Industrial | 8 | 79 | 407 |
| Martigues La Gatasse | Industrial | 10 | 121 | 759 |
| Martigues Lavéra | Industrial | 9 | 88 | 522 |
| Martigues Les Laurons | Industrial | 18 | 151 | 412 |
| Martigues Les Ventrons | Industrial | 10 | 134 | 831 |
| Martigues NDM | Urban | 4 | 71 | 380 |
| Martigues Le Pati | Industrial | 6 | 36 | 230 |
| Miramas ville | Urban | 6 | 23 | 115 |
| Port de Bouc La lèque | Urban | 15 | 126 | 375 |
| Port de Bouc Castillon | Industrial | 11 | 73 | 292 |
| Port de Bouc EDF | Urban | 10 | 70 | 274 |
| Port Saint Louis | Industrial | 4 | 27 | 134 |
| Rognac les Barjaquets | Industrial | 4 | 69 | 350 |
| Salon-de-Provence | Urban | 4 | 19 | 83 |
| Sausset les Pins | Industrial | 10 | 79 | 433 |
| Vitrolles | Urban | 7 | 39 | 164 |
|
| ||||
| Remaining part of the regional area | ||||
|
| ||||
| Arles | Urban | 3 | 12 | 58 |
| Les Pennes-Mirabeau | Urban | 3 | 24 | 132 |
| Marseille Cinq-Avenues | Urban | 4 | 25 | 125 |
| Nice Pellos | Traffic | 4 | 18 | 43 |
| Peillon | Industrial | 4 | 10 | 22 |
| Contes | Industrial | 1 | 5 | 20 |
Figure 3From SO2 concentrations grid to urban exposure estimation.
Figure 4SO2 exposure estimations by district (2008 data).
Distribution of estimated SO2 and PM10 concentrations by district (2008 data).
| Pollutant indicator | Mean | Minimum | Centile20 | Centile40 | Centile60 | Centile80 | Maximum |
|---|---|---|---|---|---|---|---|
| PM10 | 29.8 | 27.9 | 28.8 | 29.3 | 30.8 | 32.2 | 33.6 |
| SO2 | 4.4 | 2.1 | 3.4 | 4.2 | 4.6 | 6.4 | 12.4 |
Annual mean, maximum daily mean, and maximum hourly mean of PM10 concentrations (µg·m−3) measured by monitoring stations located in the study area and in the remaining part of the regional area (2008 data).
| Monitoring station | Type | Annual mean | Maximum daily mean |
|---|---|---|---|
| Study area | |||
|
| |||
| Chateauneuf/La Mède | Industrial | 32 | 102 |
| Fos-sur-Mer/les Carabins | Urban | 31 | 93 |
| Marignane ville | Urban | 33 | 106 |
| Martigues l'île | Urban | 27 | 84 |
| Miramas ville | Urban | 28 | 86 |
| Port de Bouc La lèque | Urban | 32 | 87 |
| Port Saint Louis | Industrial | 29 | 82 |
| Rognac les Barjaquets | Industrial | 27 | 93 |
| Salon-de-Provence | Urban | 31 | 94 |
|
| |||
| Remaining part of the regional area | |||
|
| |||
| Arles | Urban | 29 | 90 |
| Marseille Cinq-Avenues | Urban | 29 | 87 |
| Marseille Saint Louis | Urban | 31 | 82 |
| Marseille Thiers | Urban | 27 | 76 |
| Marseille Timone | Traffic | 33 | 88 |
| Aix Ecole d'Art | Urban | 28 | 83 |
| Aix jas de Bouffan | Urban | 27 | 82 |
| Aix Roy René | Traffic | 32 | 86 |
| Gardanne | Industrial | 37 | 101 |
| Hyères | Urban | 26 | 74 |
| Toulon Chalucet | Urban | 28 | 80 |
| Toulon foch | Traffic | 38 | 131 |
| Avignon Mairie | Urban | 25 | 80 |
| Le Pontet | Urban | 31 | 309 |
| Antibes Jean Moulin | Suburban | 34 | 71 |
| Cannes Broussailles | Urban | 35 | 69 |
| Nice aéroport | Observation | 34 | 74 |
| Cagnes sur Mer | Urban | 31 | 74 |
| Contes | Industrial | 43 | 100 |
| Peillon | Industrial | 39 | 105 |
Number of cases and distribution by quartiles for each hospitalization indicator between 2004 and 2007.
| Hospitalization indicators | Cases | Min | Q25 | Q50 | Q75 | Max |
|---|---|---|---|---|---|---|
| All cardiovascular diseases | 26,108 | 188 | 397 | 585 | 1,319 | 3,002 |
| Heart diseases | 14,506 | 90 | 200 | 315 | 752 | 1,729 |
| Coronary heart diseases | 4,684 | 29 | 71 | 105 | 258 | 577 |
| Coronary heart diseases with heart rate disorders | 808 | 0 | 13 | 17 | 41 | 99 |
| Myocardial infarction | 1,545 | 8 | 19 | 37 | 93 | 223 |
| Stroke | 4,008 | 19 | 57 | 89 | 230 | 553 |
| Heart rate disorders | 2,026 | 10 | 26 | 47 | 125 | 267 |
|
| ||||||
| All respiratory diseases | 16,107 | 117 | 188 | 317 | 872 | 1,823 |
| Respiratory infections | 4,574 | 21 | 51 | 92 | 287 | 664 |
| Pneumonia | 2,839 | 15 | 34 | 57 | 183 | 394 |
| Asthma | 937 | 2 | 9 | 17 | 54 | 131 |
| Exacerbation of chronic obstructive pulmonary disease (COPD) | 1,213 | 3 | 13 | 24 | 69 | 160 |
|
| ||||||
| All cancers | 10,416 | 89 | 159 | 249 | 499 | 1,251 |
| Breast cancer | 1,441 | 14 | 24 | 34 | 53 | 183 |
| Lung cancer | 879 | 3 | 13 | 21 | 50 | 119 |
| Bladder cancer | 515 | 1 | 8 | 14 | 26 | 68 |
| Malignant non-Hodgkin's lymphoma | 311 | 1 | 5 | 7 | 15 | 36 |
| Acute leukemia | 138 | 0 | 2 | 4 | 7 | 15 |
| Myeloma | 121 | 0 | 1 | 2 | 6 | 18 |
RR of respiratory hospitalizations and 95% credible interval (CI) in children.
| Hospitalizations indicators | Exposure class | RR | IC 95% |
|---|---|---|---|
| Reference | 1 | ||
| All respiratory diseases | Medium | 0.93 | [0.77–1.15] |
| High | 0.86 | [0.68–1.10] | |
|
| |||
| Reference | 1 | ||
| Respiratory infections | Medium |
|
|
| High | 0.79 | [0.59–1.06] | |
|
| |||
| Reference | 1 | ||
| Pneumonia | Medium | 0.67 | [0.41–1.17] |
| High | 0.70 | [0.38–1.36] | |
|
| |||
| Reference | 1 | ||
| Asthma | Medium | 0.71 | [0.49–1.04] |
| High | 0.84 | [0.54–1.35] | |
RR of cardiovascular, respiratory and cancer hospitalizations and 95% credible interval (CI) in adults.
| Hospitalizations indicators | Exposure class | Males | Females | ||
|---|---|---|---|---|---|
| RR | CI 95% | RR | CI 95% | ||
| All cardiovascular diseases | Reference | 1 | 1 | ||
| Medium | 1.03 | [0.95–1.11] | 1.01 | [0.90–1.12] | |
| High | 0.96 | [0.88–1.05] | 0.91 | [0.80–1.04] | |
| Heart diseases | Reference | 1 | 1 | ||
| Medium | 1.08 | [0.97–1.19] | 1.13 | [0.96–1.32] | |
| High | 0.98 | [0.87–1.11] | 0.99 | [0.82–1.19] | |
| Coronary heart diseases | Reference | 1 | 1 | ||
| Medium | 1.13 | [0.93–1.36] | 1.22 | [0.87–1.65] | |
| High | 1.07 | [0.86–1.34] | 1.11 | [0.76–1.61] | |
| Myocardial infarction | Reference | 1 | 1 | ||
| Medium | 1.13 | [0.94–1.37] |
|
| |
| High |
|
|
|
| |
| Heart rate disorders | Reference | 1 | 1 | ||
| Medium | 1.15 | [0.98–1.35] | 1.01 | [0.81–1.31] | |
| High | 1.16 | [0.98–1.40] | 1.05 | [0.80–1.40] | |
| Coronary heart diseases with heart rate disorders | Reference | 1 | 1 | ||
| Medium | 0.94 | [0.73–1.20] | 1.06 | [0.76–1.47] | |
| High | 1.05 | [0.73–1.52] | 0.90 | [0.61–1.31] | |
| Stroke | Reference | 1 | 1 | ||
| Medium | 0.97 | [0.80–1.19] | 1.07 | [0.82–1.37] | |
| High | 1.07 | [0.86–1.34] | 0.86 | [0.60–1.15] | |
|
| |||||
| All respiratory diseases | Reference | 1 | 1 | ||
| Medium | 0.97 | [0.84–1.10] | 1.08 | [0.90–1.27] | |
| High | 1.01 | [0.86–1.20] | 1.05 | (0.86–1.29] | |
| Respiratory infections | Reference | 1 | 1 | ||
| Medium | 0.87 | [0.68–1.11] | 0.85 | [0.65–1.09] | |
| High | 1.00 | [0.76–1.32] | 0.97 | [0.73–1.30] | |
| Pneumonia | Reference | 1 | 1 | ||
| Medium | 0.87 | [0.68–1.13] | 0.80 | [0.63–1.03] | |
| High | 0.95 | [0.72–1.29] | 0.93 | [0.69–1.24] | |
| Acute COPD | Reference | 1 | 1 | ||
| Medium | 0.87 | [0.57–1.31] | 1.16 | [0.77–1.80] | |
| High | 0.80 | [0.49–1.32] | 0.97 | (0.59–1.64] | |
|
| |||||
| All cancers | Reference | 1 | 1 | ||
| Medium | 0.98 | [0.89–1.07] | 1.00 | [0.91–1.11] | |
| High | 0.90 | [0.81–1.01] | 1.03 | [0.92–1.15] | |
| Lung cancer | Reference | 1 | 1 | ||
| Medium | 1.02 | [0.81–1.29] | 0.79 | [0.51–1.28] | |
| High | 1.09 | [0.84–1.43] | 1.05 | [0.65–1.78] | |
| Breast cancer | Reference | na | na | 1 | |
| Medium | na | na | 1.07 | [0.91–1.25] | |
| High | na | na | 0.99 | [0.82–1.20] | |
| Bladder cancer | Reference | 1 | 1 | ||
| Medium | 0.83 | [0.56–1.26] | 1.07 | [0.58–2.12] | |
| High | 0.76 | [0.48–1.23] | 0.81 | [0.38–1.70] | |
| Acute leukemia | Reference | 1 | 1 | ||
| Medium | 1.86 | [0.87–4.13] | 1.08 | [0.38–3.97] | |
| High |
|
| 0.94 | [0.29–4.24] | |
| Myeloma | Reference | 1 | 1 | ||
| Medium | 1.35 | [0.54–3.61] | 0.73 | [0.32–1.62] | |
| High | 1.65 | [0.57–5.07] | 0.40 | [0.15–1.02] | |
| Malignant non-Hodgkin's lymphoma | Reference | 1 | 1 | ||
| Medium | 0.81 | [0.52–1.23] | 0.88 | [0.51–1.59] | |
| High | 0.61 | [0.35–1.00] | 0.86 | [0.47–1.63] | |
Na: not available.